Madrigal Pharmaceuticals, Inc. (MDGL) annual balance sheet — 23-year assets, liabilities & equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 |
|---|
| Total Current Assets | 1.18B | 1.25B | 1.03B | 637.28M | 361.37M | 271.68M | 285.16M | 440.2M | 485.2M | 192.01M | 41.21M | 363.58K | 99.35M | 92.24M | 101.39M | 40.29M | 51.52M | 44.57M | 91.22M | 117M | 47.63M | 62.95M | 126.02M | 77.06M |
| Cash & Short-Term Investments | 817.93M | 983.56M | 926.25M | 634.13M | 358.77M | 270.35M | 284.15M | 439.05M | 483.72M | 191.53M | 40.5M | 66.57M | 97.69M | 91.48M | 100.6M | 39.73M | 50.97M | 44.16M | 73.56M | 115.58M | 46.82M | 62.06M | 124.97M | 76.23M |
| Cash Only | 232.19M | 198.69M | 100.02M | 99.92M | 331.55M | 36.27M | 54M | 46.7M | 57.38M | 148.63M | 40.5M | 34.97M | 46.02M | 48.49M | 81.51M | 30.07M | 31.31M | 44.16M | 52.05M | 115.58M | 33.69M | 23.81M | 42.74M | 36.06M |
| Short-Term Investments | 585.74M | 784.87M | 826.23M | 534.22M | 27.23M | 234.08M | 230.15M | 392.35M | 426.34M | 42.9M | 0 | 31.61M | 51.67M | 42.99M | 19.09M | 9.65M | 19.66M | 0 | 21.52M | 0 | 13.14M | 38.25M | 82.23M | 40.16M |
| Accounts Receivable | 187.36M | 134.48M | 53.82M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.33K | 0 | 0 | 0 | 0 | 116K | 0 | 16M | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | 41.44 | 51.21 | 109.06 | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.86 | - | 2.23K | - | - | - | - | - |
| Inventory | 112.07M | 74.84M | 34.07M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.33K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 371.74 | 486.52 | 1.99K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 64.95M | 52.89M | 18.79M | 3.15M | 2.6M | 0 | 0 | 1.15M | 1.48M | 485K | 0 | 0 | 1.66M | 0 | 0 | 0 | 0 | 419K | 151K | 83K | 540K | 457K | 457K | 345K |
| Total Non-Current Assets | 45.02M | 13.82M | 9.32M | 3.27M | 1.2M | 1.65M | 1.83M | 1.86M | 227K | 301K | 3K | 420K | 1.33M | 2.96M | 1.63M | 2.04M | 2.55M | 4.34M | 6.03M | 5.65M | 7.16M | 8.26M | 6M | 3.33M |
| Property, Plant & Equipment | 14.24M | 6.44M | 4.59M | 3.27M | 1.2M | 1.65M | 1.83M | 1.86M | 227K | 301K | 2.95K | 420K | 1.02M | 1.55M | 1.17M | 1.41M | 2.18M | 3.98M | 5.93M | 5.58M | 6.07M | 8.13M | 4.8M | 3.25M |
| Fixed Asset Turnover | 124.27x | 148.87x | 39.24x | - | - | - | - | - | - | - | - | - | - | - | - | 5.39x | 6.79x | 36.26x | 0.44x | 0.13x | - | - | 0.04x | 0.40x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 7.28M | 7.38M | 4.73M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 23.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 305K | 1.41M | 458K | 631K | 366K | 358K | 103K | 76K | 1.09M | 133K | 1.2M | 82K |
| Total Assets | 1.23B | 1.26B | 1.04B | 640.55M | 362.57M | 273.33M | 287M | 442.06M | 485.43M | 192.31M | 41.21M | 68.19M | 100.67M | 95.2M | 103.02M | 42.32M | 54.07M | 48.91M | 97.25M | 122.65M | 54.79M | 71.21M | 132.02M | 80.39M |
| Asset Turnover | 0.93x | 0.76x | 0.17x | - | - | - | - | - | - | - | - | - | - | - | - | 0.18x | 0.27x | 2.95x | 0.03x | 0.01x | - | - | 0.00x | 0.02x |
| Asset Growth % | 63.27% | 20.85% | 62.71% | 76.67% | 32.65% | -4.76% | -35.08% | -8.93% | 152.42% | 366.67% | -39.57% | -32.26% | 5.75% | -7.59% | 143.4% | -21.72% | 10.54% | -49.71% | -20.71% | 123.86% | -23.06% | -46.06% | 64.23% | - |
| Total Current Liabilities | 338.26M | 310.29M | 169.28M | 118.55M | 115.89M | 76.84M | 46.56M | 25.13M | 8.44M | 10.05M | 4.8M | 49.28M | 30.89M | 32.21M | 23.49M | 15.15M | 16.74M | 16.47M | 33.32M | 20.77M | 11.55M | 14.47M | 12.88M | 3.5M |
| Accounts Payable | 60.8M | 48.88M | 43.6M | 28.04M | 23.83M | 21.38M | 1.02M | 1.18M | 2.49M | 1.93M | 762K | 102.29K | 3.14M | 6.59M | 5.66M | 3.47M | 1.93M | 3.96M | 3.33M | 2.49M | 2.63M | 3.36M | 2.88M | 209K |
| Days Payables Outstanding | 223.93 | 317.74 | 2.55K | - | - | - | 788.12 | 3.84K | 9.46K | 9.14K | 1000K | - | 1.7K | 4.66K | 2.8K | 864.38 | - | - | - | - | 262.84 | - | 336.43 | - |
| Short-Term Debt | 1.7M | 1.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49.1M | 9.26M | 9.49M | 7.94M | 4.23M | 0 | 0 | 2.17M | 2.41M | 2.33M | 1.92M | 537K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -43K | -42K | -42K | -13K | -12K | 4.57M | 4.65M | 12.59M | 5.35M | 457K | 457K | 457K | 345K |
| Other Current Liabilities | 241.43M | 260.39M | 34.96M | 17.03M | 14.86M | 6.77M | 4.69M | 2.78M | 1.8M | 0 | 0 | 43K | 14.64M | 12.95M | 6.6M | 4.52M | 3.33M | 3.81M | 12.3M | 1.34M | 4.93M | 7.85M | 8.35M | 0 |
| Current Ratio | 3.50x | 4.01x | 6.10x | 5.38x | 3.12x | 3.54x | 6.13x | 17.52x | 57.46x | 19.10x | 8.58x | 0.01x | 3.22x | 2.86x | 4.32x | 2.66x | 3.08x | 2.71x | 2.74x | 5.63x | 4.12x | 4.35x | 9.79x | 22.04x |
| Quick Ratio | 3.16x | 3.77x | 5.90x | 5.38x | 3.12x | 3.54x | 6.13x | 17.52x | 57.46x | 19.10x | 8.58x | 0.01x | 3.22x | 2.86x | 4.32x | 2.66x | 3.08x | 2.71x | 2.74x | 5.63x | 4.12x | 4.35x | 9.79x | 22.04x |
| Cash Conversion Cycle | 189.26 | 219.99 | -449.07 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 345.61M | 346.61M | 118.59M | 116.67M | 49.29M | 387K | 468K | 361K | 0 | 0 | 0 | 0 | 4.65M | 13.9M | 4.46M | 12.4M | 13.85M | 7.53M | 122.72M | 76.98M | 44.99M | 4.26M | 1.19M | 0 |
| Long-Term Debt | 340.33M | 346.61M | 117.57M | 115.48M | 49.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.61M | 13.82M | 4.46M | 12.39M | 11.67M | 0 | 6.29M | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 22.11M | 6.73M | 1.02M | 1.19M | 0 | 387K | 468K | 361K | 0 | 0 | 0 | 0 | 43K | 85K | 1K | 14K | 26K | 799K | 2.01M | 2.81M | 3.17M | 4.26M | 1.19M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -26K | -799K | -114.42M | -74.17M | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | -6.73M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41.82M | 0 | 0 | 0 |
| Total Liabilities | 683.87M | 656.9M | 287.86M | 235.21M | 165.18M | 77.22M | 47.02M | 25.49M | 8.44M | 10.05M | 4.8M | 17.79M | 35.54M | 46.11M | 27.95M | 27.55M | 30.59M | 24M | 156.04M | 97.75M | 56.54M | 18.73M | 14.06M | 3.5M |
| Total Debt | 347.31M | 354.36M | 119.57M | 117.19M | 49.89M | 797K | 786K | 676K | 0 | 0 | 0 | 4.65M | 13.91M | 23.4M | 12.4M | 16.65M | 11.89M | 2.06M | 10.48M | 5.22M | 5.5M | 6.17M | 1.73M | 0 |
| Net Debt | 115.12M | 155.67M | 19.55M | 17.28M | -281.66M | -35.47M | -53.22M | -46.02M | -483.72M | -191.53M | -40.5M | -30.32M | -32.12M | -25.09M | -69.11M | -13.43M | -19.42M | -42.09M | -41.57M | -110.36M | -28.19M | -17.64M | -41.01M | -36.06M |
| Debt / Equity | 0.64x | 0.59x | 0.16x | 0.29x | 0.25x | 0.00x | 0.00x | 0.00x | - | - | - | 0.09x | 0.21x | 0.48x | 0.17x | 1.13x | 0.51x | 0.08x | - | 0.21x | - | 0.12x | 0.01x | - |
| Debt / EBITDA | -1.11x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.02x | - | - | - | - | - | - |
| Net Debt / EBITDA | -0.37x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.51x | - | - | - | - | - | - |
| Interest Coverage | -25.80x | -11.92x | -30.76x | -28.39x | -73.51x | - | - | - | - | - | -21.63x | -3.05x | -37.99x | -33.25x | -32.96x | -23.32x | -64.85x | 254.49x | -188.40x | - | - | - | - | - |
| Total Equity | 543.45M | 602.69M | 754.38M | 405.33M | 197.39M | 196.11M | 239.97M | 416.56M | 476.98M | 182.26M | 36.41M | 50.41M | 65.14M | 49.09M | 75.07M | 14.77M | 23.48M | 24.91M | -58.79M | 24.9M | -1.75M | 52.48M | 117.96M | 76.89M |
| Equity Growth % | -81.92% | -20.11% | 86.11% | 105.35% | 0.65% | -18.28% | -42.39% | -12.67% | 161.71% | 400.57% | -27.77% | -22.61% | 32.68% | -34.6% | 408.1% | -37.08% | -5.75% | 142.37% | -336.15% | 1525.07% | -103.33% | -55.51% | 53.41% | - |
| Book Value per Share | 18.72 | 26.86 | 35.46 | 21.69 | 11.52 | 11.86 | 15.54 | 27.06 | 32.24 | 14.88 | 7.00 | 294.76 | 23.15 | 24.21 | 44.23 | 10.96 | 20.36 | 25.55 | -61.00 | 26.84 | -2.75 | 82.54 | 220.73 | 123.15 |
| Total Shareholders' Equity | 543.45M | 602.69M | 754.38M | 405.33M | 197.39M | 196.11M | 239.97M | 416.56M | 476.98M | 182.26M | 36.41M | 50.41M | 65.14M | 49.09M | 75.07M | 14.77M | 23.48M | 24.91M | -58.79M | 24.9M | -1.75M | 52.48M | 117.96M | 76.89M |
| Common Stock | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 1K | 1.2K | 14K | 11K | 9K | 7K | 5K | 4K | 3K | 3K | 3K | 2K | 2K | 3K | 3K |
| Retained Earnings | -2.18B | -2.09B | -1.8B | -1.34B | -962.66M | -667.31M | -425.46M | -223.22M | -139.27M | -106.46M | -75.31M | -706.24M | -637.57M | -551.41M | -461.22M | -398.43M | -351.05M | -313.58M | -392.67M | -300.05M | -236.56M | -179.29M | -110.42M | -64.49M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 1.08M | 873K | 468K | 468K | -32K | -80K | 47K | 216K | -319K | -31K | 25.4K | 4K | 4K | 17K | 2K | 3K | -3K | -16.03M | 15K | -11.52M | 2K | -7.27M | -10.55M | -2.77M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying MDGL stock.
As of 2025, Madrigal Pharmaceuticals, Inc. (MDGL) had total assets of $1.26B including $1.25B in current assets.
Madrigal Pharmaceuticals, Inc. (MDGL) carries total debt of $354.4M, offset by $983.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Madrigal Pharmaceuticals, Inc. (MDGL) has total shareholders' equity (book value) of $602.7M ($26.86 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Madrigal Pharmaceuticals, Inc. (MDGL) reported a current ratio of 4.01x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.